Archives

The European Union Aviation Safety Agency (EASA) and European Centre for Disease Prevention and Control (ECDC) issued an update to the health safety measures for air travel, paving the way for a relaxation of the need to wear medical masks on board a flight, but noting that a face mask is still one of the […]

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 May 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia’s invasion of Ukraine, hepatitis, Ebola, Middle East respiratory syndrome coronavirus, chikungunya and dengue.

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 April 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia’s invasion of Ukraine, hepatitis, Ebola, cholera and poliomyelitis.

This document offers a more detailed overview of the available scientific and epidemiological evidence and public health considerations in order to support decisions on the implementation of a second booster dose of COVID-19 vaccine.

A continuous high incidence or a large surge in cases in the early summer would imply a large benefit from an early second booster roll-out but optimal timing will largely depend on trends in infections ECDC says in the latest technical report on a second mRNA COVID-19 vaccine booster dose.

Is mRNA technology something completely new? How does it work and how is it used in developing vaccines for infectious diseases?

How was it possible to develop COVID-19 vaccines so quickly? Watch our animation to learn more about their production.